Cardio-Oncologists manage the cardiovascular health of patients undergoing cancer treatment, addressing heart-related complications that can arise from therapies such as chemotherapy, radiation, and immunotherapy. These treatments can lead to issues like heart failure, arrhythmias, and high blood pressure. Cardio-oncologists monitor heart function during and after treatment using diagnostic tools like echocardiograms, electrocardiograms, and cardiac MRIs to detect early signs of heart damage. This allows for timely interventions to reduce long-term cardiovascular risks while ensuring cancer treatments are effective.
They also provide guidance on lifestyle modifications, including diet and exercise, to help manage cardiovascular health during cancer treatment. They work closely with oncologists to adjust treatment plans as needed, ensuring that heart health is maintained without compromising the effectiveness of cancer therapies. By offering ongoing monitoring and tailored care, cardio-oncologists help patients navigate the complexities of cancer treatment, ensuring a balanced approach to both cancer recovery and cardiovascular well-being. Their comprehensive care improves the overall quality of life for cancer patients and survivors while minimizing the risk of heart complications in the future. Cardio-oncologists are essential in preventing long-term heart damage in cancer survivors, who may face an increased risk of cardiovascular disease later in life. They provide ongoing cardiovascular care even after cancer treatment is complete, ensuring that survivors maintain heart health for years to come.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt